Alamar

• Genetic Insights Into Protective Effects of GLP-1 Receptor Agonists on Stroke and Alzheimer Disease Across Ancestries

  Consulting or advice, Shares or equity, Board or leadership role, 25 Sept 2026

• Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs

  Consulting or advice, Board or leadership role, 22 Sept 2026

• Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers

  Consulting or advice, Board or leadership role, 13 Sept 2026

• A multiancestry polygenic risk score for Alzheimer's disease is associated with cognitive decline and neuropathological hallmarks in diverse populations

  Consulting or advice, Shares or equity, Board or leadership role, 27 Aug 2026

• Lifestyle and psychosocial protective factors drive healthy aging and modulate inflammatory and metabolic pathways

  Consulting or advice, Board or leadership role, 5 Aug 2026

• A plasma-based protein signature combining NPTXR, ACHE, and p-tau217 predicts progression to symptomatic Alzheimer's disease

  Consulting or advice, Shares or equity, Board or leadership role, 1 Aug 2026

• Interpreting p-tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults

  Consulting or advice, Board or leadership role, 1 Aug 2026

• Multi-modal deep learning and explainable AI for predicting multiple dementia-related neuropathologies from brain MRI, clinical, and genetic data

  Consulting or advice, 27 Jul 2026

• Midlife sensory and motor measures among best predictors in parsimonious models of long-term cognitive decline and incidence of cognitive impairment in aging adults

  Consulting or advice, 1 Feb 2026

• Integrative epigenetics and transcriptomics identify aging genes in human blood

  Consulting or advice, 19 Jan 2026

• Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease

  Consulting or advice, Shares or equity, Board or leadership role, 20 Nov 2025

• A unified framework for systematic curation and evaluation of aging biomarkers

  Consulting or advice, 4 Nov 2025

Sources: pubmed.ncbi.nlm.nih.gov

• Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms

  NPJ dementia, 4 Sept 2026

• Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217

  Alzheimer's & dementia : the journal of the Alzheimer's Association, 6 Aug 2026

• Clinical use of blood ptau217: plasma or serum? The matrix matters

  AAIC 2025 abstract, 23 Dec 2025